Success Stories: An Associate Director from India Based in Massachusetts who Specializes in Biostatistics Received EB-1A Approval by Presenting a Customized Petition
Client’s Testimonial:
“Good news!! I received the approval notice earlier today.”
On October 10th, 2019, we received another EB-1A (Alien of Extraordinary Ability) approval for an Associate Director in the field of Biostatistics (Approval Notice).
General Field: Biostatistics
Position at the Time of Case Filing: Associate Director
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: October 10th, 2019
Processing Time: 7 months, 6 days
Case Summary:
North America Immigration Law Group (NAILG) has successfully attained close to 15,000 I-140 immigration petitions. Our sterling reputation as a law firm that offers customized I-140 petitions and unprecedented insight into how the USCIS adjudicates cases are reasons why clients from all over the world seek our help for their green cards. In this case, an associate director from India, one of the few leading experts who conduct valuable biostatistical research to further benefit the health and longevity of the American public retained our firm to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf. We handled his case with utmost attentiveness, and to our delight, his EB-1A petition was approved in 7 months and 6 days.
Our client’s specialized research brings enormous benefits on medical treatments and pharmaceutical development, especially for rare diseases with high unmet need. By submitting evidence of his 7 peer-reviewed scientific articles and experience of judging the work of his peers for 10 times, we demonstrated to the USCIS that he is an extraordinary researcher who deserves to remain in the US to conduct his impactful research on design and analysis of clinical trials for new treatments of rare diseases and conditions. We also detailed the 270 times his work was cited by independent and leading researchers from prestigious institutions and organizations around the world. The strong statistical evidence he supplied contributes to the safety and efficacy of new treatments for patients with cystic fibrosis, positively affecting patient health by forging new research and improved biopharmaceutical developments.
The EB-1A petition received a boost from the recommendation letters contributed by other renowned experts in the field. These letters detailed our client’s academic achievements and research projects, and shed light on his efforts in aiding the US to improve the pharmaceutical, biological, and medical industries and ensuring the healthcare for patients on a broad scale. To support our client’s continued stay in the country, one recommender wrote: “Therefore, [Client]’s biostatistical work further fortifies America’s competitive edge and leadership in this lucrative market by effectively analyzing and supporting the introduction of new drugs. The importance of [Client]’s work to the nation, in conjunction with his impressive history of accomplishment, makes it abundantly clear that his continuing work will remain in high demand for many years to come”.This statement succinctly explained why our client’s continued stay in the United States is in the best interest of the country.
We are glad that our client has surpassed this first, significant hurdle in the green card process, and we truly appreciate our client for trusting us with the preparation of his EB-1A case and for giving us an opportunity to be a part of his success story.